A case of the giant thrombus on atrial lead of a patient who has a DDD permanent pacemaker

Halit Acet1, Hamza Duygu, Faruk Ertas

  • 1Department of Cardiology, Ataturk Training and Research Hospital, Izmir, Turkey.

Insights

A large blood clot formed on the atrial lead of a patient with a DDD dual-chamber permanent pacemaker. This case highlights a rare complication associated with pacemaker use.

Area of Science:

  • Cardiology
  • Medical Device Technology

Background:

  • Permanent pacemakers, specifically DDD dual-chamber devices, are crucial for managing bradyarrhythmias.
  • Atrial leads are essential components responsible for sensing atrial activity and delivering pacing stimuli.

Observation:

  • A rare and significant complication involving a giant thrombus formation was observed on the atrial lead.
  • The thrombus developed in a patient with an existing DDD dual-chamber permanent pacemaker.

Findings:

  • The presence of a giant thrombus on the atrial lead represents a potentially serious complication.
  • This finding underscores the importance of monitoring pacemaker components for unforeseen adverse events.

Implications:

  • This case highlights the need for vigilance regarding potential complications, such as thrombus formation, in patients with permanent pacemakers.
  • Further research may be warranted to understand the risk factors and optimal management strategies for pacemaker lead-related thrombi.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...